Articles for category: Most Popular

Russ Cohen

Most Popular

3 Billionaire-Owned Stocks Worth Investing In Insightful Investment Opportunities in Billionaire-Owned Stocks

When it comes to investing in stocks, following the lead of billionaires is a strategy that some investors find appealing. Billionaires often hold shares at attractive valuations or with significant dividend gains. While their motivations may be unknown, their choices can offer insights for smaller investors. Let’s explore three such stocks that billionaires have shown ...

Russ Cohen

Most Popular

Investing in the Metaverse: A Long-Term Bet on Virtual Reality Investing in the Metaverse: A Long-Term Bet on Virtual Reality

Disney: The Magic of a Hidden Gem Despite facing headwinds, Disney (NYSE:DIS) stands as a magical company pushing the boundaries of technology. As its stock price hovers around $100, initiatives in the metaverse and VR hint at a future escape from underperformance. Collaborations with companies like Apple (NASDAQ:AAPL) reveal Disney’s potential to soar with spatial ...

Russ Cohen

Most Popular

Unleashing Amazon: A Bullish Dive into Stock Potential

Amazon (NASDAQ: AMZN) has ridden a rollercoaster of highs and lows, emerging as a titan in the stock market post the tech sector turmoil of 2022. Weathering a storm that saw its stock plummet by half, Amazon has since orchestrated a remarkable recovery. With a staggering 123% spike since January 1, 2023, and a solid ...

Russ Cohen

Most Popular

Investing in Water Stocks for Long-Term Growth

As we stand on the precipice of a global water crisis, savvy investors are eyeing companies poised to capitalize on the challenge of poor water infrastructure — a challenge that, if left unaddressed, could devastate economies and communities alike. In this landscape, water stocks emerge as flag-bearers of opportunity, promising immense wealth creation in the ...

Russ Cohen

Most Popular

Exploring Novo Nordisk’s Recent Achievements Exploring Novo Nordisk’s Recent Achievements in the Pharmaceutical Realm

Novo Nordisk (NYSE: NVO) has solidified its status as a pharmaceutical heavyweight with its impressive lineup of glucagon-like peptide-1 (GLP-1) medications. Among them, Ozempic, Rybelsus, Saxenda, and Wegovy stand out as key offerings in the company’s portfolio. While Ozempic holds a prominent position as Novo Nordisk’s flagship product for diabetes treatment, the spotlight is now ...

Russ Cohen

Most Popular

The Tempest of Microsoft’s Financial Seas: A Deep Dive for Investors

Earnings Estimates: The North Star in a Sea of Volatility Amidst the turbulent waters of the stock market, earnings estimates act as a guiding star for investors navigating the storm. Rather than chasing fickle trends and rumors, focusing on a company’s earnings projection provides a sturdy foundation for investment decisions. The fair value of a ...

Russ Cohen

Most Popular

Insights into Top Performing Stocks Post Cooler PCE Data Insights into Top Performing Stocks Post Cooler PCE Data

The Significance of Core PCE Data The Personal Consumption Expenditures (PCE) Price Index serves as a barometer for the evolving landscape of consumer spending and price changes in the U.S. economy. Particularly, the Core PCE metric, excluding volatile elements like food and energy, offers the Federal Reserve valuable insights into inflation trends. Positive Economic Indicators ...